Risk factors for predicting medium-giant coronary artery aneurysms in Kawasaki disease
Immunologic Research,
Год журнала:
2025,
Номер
73(1)
Опубликована: Фев. 17, 2025
Язык: Английский
Unveiling the anti-inflammatory mechanism of exogenous hydrogen sulfide in Kawasaki disease based on network pharmacology and experimental validation
Scientific Reports,
Год журнала:
2025,
Номер
15(1)
Опубликована: Март 3, 2025
Kawasaki
disease
(KD)
is
a
severe
pediatric
vasculitis
leading
to
coronary
artery
complications.
Hydrogen
sulfide
(H2S),
recognized
endogenous
gasotransmitter
with
anti-inflammatory
properties,
offers
potential
as
novel
treatment
for
KD
through
its
cardiovascular
benefits.
However,
the
specific
effects
and
underlying
mechanisms
remain
unclear.
The
objective
of
present
study
investigate
therapeutic
exogenous
H2S
in
using
network
pharmacology
experimental
validation.
By
online
database
searches,
total
405
pharmacological
targets
H2S,
826
KD-related
targets,
107
were
identified.
Through
PPI
analysis
Cytoscape
screening,
9
hub
genes
filtered,
namely
TNF,
IL6,
JUN,
AKT1,
IL1B,
TP53,
NFKB1,
MAPK1,
RELA.
KEGG
pathway
enrichment
indicated
that
TLR4/MyD88/NF-κB
signaling
may
play
crucial
role
on
KD.
Additionally,
vivo
experiments
confirmed
sodium
hydrosulfide
(NaHS),
an
donor,
markedly
improved
body
weight,
reduced
inflammatory
pathology
arteries,
downregulated
levels
cytokines
TNF-α,
IL-1β,
IL-6.
Furthermore,
WB
NaHS
inhibited
expression
TLR4,
MyD88,
NF-κB,
p-NF-κB.
In
brief,
it
first
reveal
attenuates
response
via
pathway,
highlighting
approach
These
findings
lay
foundation
further
development
H2S-based
therapies
management.
Язык: Английский
Intestinal Microbiota Contributes to the Development of Cardiovascular Inflammation and Vasculitis in Mice
Circulation Research,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 3, 2025
BACKGROUND:
Alterations
in
the
intestinal
microbiota
contribute
to
pathogenesis
of
various
cardiovascular
disorders,
but
how
they
affect
development
Kawasaki
disease,
an
acute
pediatric
vasculitis,
remains
unclear.
Here,
using
a
murine
model
mimicking
disease
we
assessed
contribution
vascular
inflammation.
METHODS
AND
RESULTS:
We
report
that
depleting
gut
reduces
inflammation
vasculitis.
The
lesions
was
associated
with
alterations
composition
and,
notably,
decreased
abundance
Akkermansia
muciniphila
and
Faecalibacterium
prausnitzii
.
Oral
supplementation
either
these
live
or
pasteurized
individual
bacteria
short-chain
fatty
acids
produced
by
them
attenuated
inflammation,
as
reflected
local
immune
cell
infiltrations.
Treatment
Amuc_1100,
TLR-2
signaling
outer
membrane
protein
from
,
also
reduced
severity
CONCLUSIONS:
This
study
reveals
underappreciated
microbiota-cardiovascular
axis
vasculitis
identifies
specific
commensals
regulate
mice
producing
metabolites
via
extracellular
proteins
capable
enhancing
supporting
barrier
function.
Язык: Английский